Cleared Traditional

K183332 - “BRAXX” Esophageal Brachytherapy Applicator

K183332 is an FDA 510(k) clearance for “BRAXX” Esophageal Brachytherapy Applicator, manufactured by Braxx Biotech Co., Ltd.. The device is a Class 2 Radiology device with product code JAQ cleared through the Traditional 510(k) pathway after a 134-day FDA review.

K183332 · Braxx Biotech Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
134d
Days
Class 2
Risk

K183332 is an FDA 510(k) clearance for the “BRAXX” Esophageal Brachytherapy Applicator. Classified as System, Applicator, Radionuclide, Remote-controlled (product code JAQ), Class II - Special Controls.

Submitted by Braxx Biotech Co., Ltd. (Taipei City, TW). The FDA issued a Cleared decision on April 16, 2019 after a review of 134 days - within the typical 510(k) review window.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.5700 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Braxx Biotech Co., Ltd. devices

FDA 510(k) Submission Details - K183332

510(k) Number K183332 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 03, 2018
Decision Date April 16, 2019
Days to Decision 134 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
27d slower than avg
Panel avg: 107d · This submission: 134d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JAQ Device Classification - Class 2, Special Controls

Product Code JAQ System, Applicator, Radionuclide, Remote-controlled
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.5700
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - JAQ System, Applicator, Radionuclide, Remote-controlled

All 121
Devices cleared under the same product code (JAQ) and FDA review panel - the closest regulatory comparables to K183332.
ASSISTO Universal Applicator Clamping Device
K201279 · Geomed Medizin-Technik GmbH & Co. KG · Jul 2020
CT F/S/D Compatible Applicators (Fletcher), HDR Compatible Tandem and Ovoid Applicators (Henschke), HDR CT Compatible Split Ring Applicator, Segmented Vaginal Applicator, HDR Miami Applicator HDR Brachytherapy Applicator, 2/3 Endometrial Applicator Sets, CT HDR Ring & Tandem Applicator with Rectal Retractor
K200221 · Mick Radio-Nuclear Instruments, Inc. · Feb 2020
BRAVOS Afterloader System, Transfer Guide Tubes, Length Assessment Device
K191580 · Varian Medical Systems, Inc. · Jul 2019
GM Implant Tubes, Length Cutting Gauge
K172533 · Varian Medical Systems, Inc. · Oct 2018
BRAVOS Afterloader Family: BRAVOS Afterloader System, Transfer Guide Tubes, and Length Assessment Device
K181903 · Varian Medical Systems, Inc. · Oct 2018
Varian Cervical Sleeves
K172675 · Varian Medical Systems, Inc. · May 2018